Manuel Litchman's Insider Trades & SAST Disclosures
Manuel Litchman's most recent trade in Mustang Bio Inc was a trade of 1,396 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on May 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Manuel Litchman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.35 per share. | 31 May 2024 | 1,396 | 83,024 (0%) | 0% | 0.4 | 489 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 5,000 | 111,079 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.21 per share. | 24 Apr 2022 | 1,572 | 79,420 (0%) | 0% | 4.2 | 6,618 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.15 per share. | 24 Apr 2022 | 1,248 | 80,992 (0%) | 0% | 12.1 | 15,163 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 61,000 | 1,093,987 (2%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Mustang Bio Inc | Manuel Litchman | Director | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 18 Mar 2022 | 5,000 | 1,032,987 (2%) | 0% | 0.7 | 3,695 | COMMON STOCK, PAR VALUE $0.0001 |
| Mustang Bio Inc | Manuel Litchman | Director | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 18 Mar 2022 | 5,000 | 1,098,987 (2%) | 0% | 0.5 | 2,582 | COMMON STOCK, PAR VALUE $0.0001 |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 27 Oct 2021 | 65,000 | 1,027,987 (2%) | 0% | 2.2 | 145,600 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.58 per share. | 31 Aug 2021 | 2,746 | 962,987 (2%) | 0% | 2.6 | 7,085 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 30 Jul 2021 | 86,206 | 960,241 (2%) | 0% | 2.9 | 250,859 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 61,000 | 874,035 (2%) | 0% | 0 | COMMON STOCK | |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.12 per share. | 26 Feb 2021 | 165,562 | 825,408 (2%) | 0% | 3.1 | 516,553 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.83 per share. | 26 Feb 2021 | 5,000 | 659,846 (1%) | 0% | 2.8 | 14,150 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 31 Aug 2020 | 100,000 | 654,846 (1%) | 0% | 2.9 | 291,000 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2020 | 61,000 | 554,846 (1%) | 0% | 0 | COMMON STOCK | |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.48 per share. | 31 Aug 2020 | 5,000 | 493,846 (1%) | 0% | 2.5 | 12,400 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 11 Jun 2020 | 153,846 | 488,846 (1%) | 0% | 3.3 | 500,000 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 14 May 2020 | 90,000 | 245,000 (0%) | 0% | 2.8 | 251,100 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.13 per share. | 14 May 2020 | 90,000 | 335,000 (0%) | 0% | 3.1 | 281,700 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges